Receiving regulatory clearance for a new market like Australia is a critical step for medical device companies. It not only opens up a new revenue stream but also enhances the company's reputation in the global market. Given the size and potential of the Australian market, this clearance is likely to have a positive impact on Venus Concept's stock price in the short term as investors react to the news of potential growth.